全文获取类型
收费全文 | 2922篇 |
免费 | 259篇 |
国内免费 | 61篇 |
专业分类
3242篇 |
出版年
2024年 | 12篇 |
2023年 | 67篇 |
2022年 | 98篇 |
2021年 | 107篇 |
2020年 | 99篇 |
2019年 | 153篇 |
2018年 | 127篇 |
2017年 | 84篇 |
2016年 | 77篇 |
2015年 | 110篇 |
2014年 | 178篇 |
2013年 | 169篇 |
2012年 | 132篇 |
2011年 | 187篇 |
2010年 | 140篇 |
2009年 | 111篇 |
2008年 | 116篇 |
2007年 | 112篇 |
2006年 | 106篇 |
2005年 | 114篇 |
2004年 | 113篇 |
2003年 | 72篇 |
2002年 | 70篇 |
2001年 | 37篇 |
2000年 | 38篇 |
1999年 | 32篇 |
1998年 | 41篇 |
1997年 | 32篇 |
1996年 | 34篇 |
1995年 | 39篇 |
1994年 | 48篇 |
1993年 | 22篇 |
1992年 | 46篇 |
1991年 | 24篇 |
1990年 | 36篇 |
1989年 | 29篇 |
1988年 | 29篇 |
1987年 | 20篇 |
1986年 | 25篇 |
1985年 | 22篇 |
1984年 | 27篇 |
1983年 | 13篇 |
1982年 | 18篇 |
1981年 | 14篇 |
1980年 | 18篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1970年 | 7篇 |
排序方式: 共有3242条查询结果,搜索用时 9 毫秒
31.
观察发酵乳对脓毒症患者肠黏膜屏障功能及炎症指标的影响。
选取60例确诊为脓毒症的患者, 随机分成对照组和发酵乳组, 每组各30例。对照组给予抗生素及营养支持治疗, 治疗组在常规综合治疗的基础上给予口服发酵乳治疗。在治疗前及治疗1周后分别检测并比较两组患者肠黏膜屏障功能、C-反应蛋白(CRP)、降钙素原(PCT)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)水平变化, 记录患者APACHEⅡ评分。采用SPSS 22.0软件进行数据统计。
治疗前两组患者的肠屏障功能、PCT和IL-6水平差异无统计学意义(
脓毒症患者在常规综合治疗基础上加用发酵乳可改善肠粘膜屏障功能, 减轻患者全身炎症反应。
32.
目的:探讨卵巢上皮癌中ING4 基因启动子的甲基化状态及其临床意义。方法:收集2005 年7 月至2012 年6 月哈尔滨医科
大学附属第一医院行全面分期手术并经病理检查确诊的150 例卵巢上皮癌组织标本,并以同期因子宫肌瘤或子宫腺肌症行子宫
全切除术或次全切除术并经病理检查确诊为正常卵巢组织的150 例标本作为对照组。采用甲基化特异性PCR(MSP)技术检测卵
巢上皮癌组织与正常卵巢组织中ING4 基因启动子的甲基化状态,蛋白印迹法检测ING4 蛋白的表达,并分析ING4 基因启动子
的甲基化状态与卵巢上皮癌临床病例特征的关系。结果:卵巢上皮癌组织中ING4 基因启动子的甲基化阳性率为42.7%(64/150),
明显高于正常卵巢组织(4%,6/150),差异有统计学意义(P<0.05)。ING4 基因启动子甲基化阳性的卵巢上皮癌组织中ING4蛋白
表达阴性或弱阳性;ING4 基因启动子甲基化阴性的卵巢上皮癌和正常卵巢组织中ING4 蛋白表达阳性;在64 例ING4 基因启动
子甲基化的卵巢上皮癌组织中,ING4 蛋白表达强度与ING4 基因启动子的甲基化程度呈负相关(r=-0.435,P<0.05)。卵巢上皮癌
组织中,ING4 基因甲基化的阳性率随着手术病理分期和组织学分级的增加而增加(P<0.05);卵巢透明细胞癌(55.6%,10/18)和卵
巢子宫内膜样癌(59.3%,16/27)中ING4 基因甲基化的阳性率显著高于浆液性囊腺癌(33.9%,20/59)和粘液性囊腺癌(39.1%,
18/46)(P<0.05);ING4基因启动子的甲基化状态与患者的年龄、有无腹水及淋巴结转移均无显著相关性(P>0.05)。结论:ING4 基
因启动子的甲基化可能促进了其在卵巢上皮癌组织中的表达失活,进而促进了卵巢上皮癌的生长和分化。 相似文献
33.
34.
L. M. Tai K. A. Holloway D. K. Male A. J. Loughlin I. A. Romero 《Journal of cellular and molecular medicine》2010,14(5):1101-1112
Vascular dysfunction is emerging as a key pathological hallmark in Alzheimer’s disease (AD). A leaky blood–brain barrier (BBB) has been described in AD patient tissue and in vivo AD mouse models. Brain endothelial cells (BECs) are linked together by tight junctional (TJ) proteins, which are a key determinant in restricting the permeability of the BBB. The amyloid β (Aβ) peptides of 1–40 and 1–42 amino acids are believed to be pivotal in AD pathogenesis. We therefore decided to investigate the effect of Aβ 1–40, the Aβ variant found at the highest concentration in human plasma, on the permeability of an immortalized human BEC line, hCMEC/D3. Aβ 1–40 induced a marked increase in hCMEC/D3 cell permeability to the paracellular tracer 70 kD FITC‐dextran when compared with cells incubated with the scrambled Aβ 1–40 peptide. Increased permeability was associated with a specific decrease, both at the protein and mRNA level, in the TJ protein occludin, whereas claudin‐5 and ZO‐1 were unaffected. JNK and p38MAPK inhibition prevented both Aβ 1–40‐mediated down‐regulation of occludin and the increase in paracellular permeability in hCMEC/D3 cells. Our findings suggest that the JNK and p38MAPK pathways might represent attractive therapeutic targets for preventing BBB dysfunction in AD. 相似文献
35.
An Inhibitory Role of Nitric Oxide in the Dynamic Regulation of the Blood-Brain Barrier Function 总被引:1,自引:0,他引:1
Yamauchi A Dohgu S Nishioku T Shuto H Naito M Tsuruo T Sawada Y Kataoka Y 《Cellular and molecular neurobiology》2007,27(3):263-270
1. The present study aimed at elucidating the effect of nitric oxide (NO) on blood-brain barrier (BBB) function with mouse
brain capillary endothelial (MBEC4) cells.
2. Histamine (20–100 μM) evoked NO production (1.6–7 μM) in MBEC4 cells in a dose-dependent manner.
3. The permeability coefficient of sodium fluorescein for MBEC4 cells and the cellular accumulation of rhodamine 123 in MBEC4
cells were increased dose-dependently by the addition of NO solutions (14 and 28 μM) every 10 min during a 30-min period.
4. The present study demonstrated that NO increased the permeability and inhibited the P-glycoprotein efflux pump of brain
capillary endothelial cells, suggesting that NO plays an inhibitory role in the dynamic regulation of the BBB function. 相似文献
36.
Dominique Toussaint-Demylle Jean-Marie Scheiff Stanislas Haumont 《Cell and tissue research》1990,262(1):115-123
Summary Thymic nurse cells (TNC), which are multicellular complexes composed of epithelial cells and thymocytes, were obtained from C3H-mice thymuses. They were described by means of light and electron microscopy. The morphology of epithelial cells forming isolated TNC compared to that of small tissue fragments obtained by enzymatic digestion revealed that TNC could be derived from all parts of the thymus: cortex, corticomedullary junction and medulla, the cortex being their principal source. This variety of origin, the presence of several epithelial cells inside a single TNC, the presence of non-lymphoid cells, and the various locations of eleaved desmosomes confirmed that their aspect in vitro as round and sealed structures can be considered to be an artifact due to the isolation technique used. Indeed, during this procedure, they are formed by a process of wrapping of the epithelial cytoplasm around the tightly associated thymocytes. All three epithelial cell types: cortical reticular cells, medullary reticular cells, and medullary globular cells can form TNC.A portion of this work was presented at the first Thymus Workshop. Rolduc, Netherlands, April, 1988 相似文献
37.
Exogenous arachidonic acid mediates permeability of human brain microvessel endothelial cells through prostaglandin E2 activation of EP3 and EP4 receptors 下载免费PDF全文
Siddhartha Dalvi Hieu H. Nguyen Ngoc On Ryan W. Mitchell Harold M. Aukema Donald W. Miller Grant M. Hatch 《Journal of neurochemistry》2015,135(5):867-879
The blood–brain barrier, formed by microvessel endothelial cells, is the restrictive barrier between the brain parenchyma and the circulating blood. Arachidonic acid (ARA; 5,8,11,14‐cis‐eicosatetraenoic acid) is a conditionally essential polyunsaturated fatty acid [20:4(n ? 6)] and is a major constituent of brain lipids. The current study examined the transport processes for ARA in confluent monolayers of human brain microvascular endothelial cells (HBMEC). Addition of radioactive ARA to the apical compartment of HBMEC cultured on Transwell® inserts resulted in rapid incorporation of radioactivity into the basolateral medium. Knock down of fatty acid transport proteins did not alter ARA passage into the basolateral medium as a result of the rapid generation of prostaglandin E2 (PGE2), an eicosanoid known to facilitate opening of the blood–brain barrier. Permeability following ARA or PGE2 exposure was confirmed by an increased movement of fluorescein‐labeled dextran from apical to basolateral medium. ARA‐mediated permeability was attenuated by specific cyclooxygenase‐2 inhibitors. EP3 and EP4 receptor antagonists attenuated the ARA‐mediated permeability of HBMEC. The results indicate that ARA increases permeability of HBMEC monolayers likely via increased production of PGE2 which acts upon EP3 and EP4 receptors to mediate permeability. These observations may explain the rapid influx of ARA into the brain previously observed upon plasma infusion with ARA.
38.
Michael Remesic Giorgia Macedonio Adriano Mollica Frank Porreca Victor Hruby Yeon Sun Lee 《Bioorganic & medicinal chemistry》2018,26(12):3664-3667
In an effort to improve biphalin’s potency and efficacy at the µ-(MOR) and δ-opioid receptors (DOR), a series of cyclic biphalin analogues 1–5 with a cystamine or piperazine linker at the C-terminus were designed and synthesized by solution phase synthesis using Boc-chemistry. Interestingly, all of the analogues showed balanced opioid agonist activities at all opioid receptor subtypes due to enhanced κ-opioid receptor (KOR) activity. Our results indicate that C-terminal flexible linkers play an important role in KOR activity compared to that of the other cyclic biphalin analogues with a hydrazine linker. Among them, analogue 5 is a potent (Ki?=?0.27, 0.46, and 0.87?nM; EC50?=?3.47, 1.45, and 13.5?nM at MOR, DOR, and KOR, respectively) opioid agonist with high efficacy. Based on the high potency and efficacy at the three opioid receptor subtypes, the ligand is expected to have a potential synergistic effect on relieving pain and further studies including in vivo tests are worthwhile. 相似文献
39.
40.
Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique 总被引:6,自引:0,他引:6
Choline enters brain by saturable transport at the blood-brain barrier (BBB). In separate studies, both sodium-dependent and passive choline transport systems of differing affinity have been reported at brain capillary endothelial cells. In the present study, we re-examined brain choline uptake using the in situ rat brain perfusion technique. Saturable brain choline uptake from perfusion fluid was best described by a model with a single transporter (V:(max) = 2.4-3.1 nmol/min/g; K(m) = 39-42 microM) with an apparent affinity (1/Km)) for choline five to ten-fold greater than previously reported in vivo, but less than neuronal 'high-affinity' brain choline transport (K(m) = 1-5 microM). BBB choline uptake from a sodium-free perfusion fluid using sucrose for osmotic balance was 50% greater than in the presence of sodium suggesting that sodium is not required for transport. Hemicholinium-3 inhibited brain choline uptake with a K(i) (57 +/- 11 microM) greater than that at the neuronal choline system. In summary, BBB choline transport occurs with greater affinity than previously reported, but does not match the properties of the neuronal choline transporter. The V:(max) of this system is appreciable and may provide a mechanism for delivering cationic drugs to brain. 相似文献